Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer

Lung cancer is the leading cause of cancer-related death throughout the world. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers, and lung adenocarcinoma (LUAD) is the major subtype of NSCLC.